Avacopan
Overview
Avacopan is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3989871).
API suppliers (3)
Suppliers of Avacopan evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 2 of 3 suppliers.
2 of 3 hold a GMP certificate on record in the EU or UK registers
- MAITHRI DRUGS PRIVATE LTDIndia1 active DMF GMP on record
- STHREE CHEMICALS PRIVATE LTD1 active DMF
- Hetero Labs LimitedIndia1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Avacopan expires 27 Nov 2039 and exclusivity 7 Oct 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- (2R,3S)-2-[4-(cyclopentylamino)phenyl]-1-(2-fluoro-6-methylbenzoyl)-N-[4-methyl-3-(trifluoromethyl)phenyl]piperidine-3-carboxamide
- Canonical SMILES
- CC1=C(C(=CC=C1)F)C(=O)N2CCC[C@@H]([C@@H]2C3=CC=C(C=C3)NC4CCCC4)C(=O)NC5=CC(=C(C=C5)C)C(F)(F)F
- InChIKey
- PUKBOVABABRILL-YZNIXAGQSA-N
Do you supply Avacopan? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.